IP Verse

Janssen Pharmaceutica Nv competitive analysis

Latest oppositions filed by Janssen Pharmaceutica Nv

Explore patent oppositions filed by Janssen Pharmaceutica Nv against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 8, 2026
Patent NumberTitleApplicantOpposition Date
EP2456763
Oxazine Derivatives And Their Use As Bace Inhibitors For The Treatment Of Neurological DisordersNOVARTISOct 21, 2015

Latest patents of Janssen Pharmaceutica Nv opposed by its competitors

Explore Janssen Pharmaceutica Nv's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 8, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3501542
Jan 28, 2026Esketamine For The Treatment Of Depression1
EP3490560
Jan 22, 2025Methods Of Treating Prostate Cancer4
EP2234617
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters24
EP4005555
May 15, 2024Methods For Ensuring Resuspension Of Paliperidone Palmitate Formulations2
EP4025188
Jan 10, 2024Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations3
EP4025187
Jan 3, 2024Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations2
EP3744326
Dec 6, 2023Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters10
EP3609497
Oct 12, 2022Combination Therapy For Prostate Cancer3
EP3311374
Jul 22, 2020Devices And Methods For Drug Administration And Mixing, And Training Of Proper Techniques Therefor2
EP3280416
Apr 22, 2020Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters11

Latest PTAB cases involving Janssen Pharmaceutica Nv

Discover the latest PTAB cases involving Janssen Pharmaceutica Nv, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 10, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Janssen Pharmaceutica Nv

IPR2020-00440Feb 7, 2020MYLAN LABORATORIESJANSSEN PHARMACEUTICAInstitution Denied

Peer Comparison New

IP litigation analysis comparing Janssen Pharmaceutica Nv with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 8, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
JANSSEN PHARMACEUTICA264 - 1
GENERICS UK320 - - -
HAMM&WITTKOPP PATENTANWÄLTE PARTMBB96 - - -
TEVA PHARMACEUTICAL INDUSTRIES LTD2747 - -